A successful partnership leads to early Alzheimer’s detection and treatment
Valerie Daggett, David and Nancy Auth Endowed Professor in Bioengineering, has been interested in [...]
Three UW Bioengineering Professors elected to join the Washington State Academy of Sciences
Three UW BioE faculty members have been selected to join the Washington State Academy of Sciences (WSAS): Valerie Daggett, Paul Kinahan and Ruikang Wang. T
UW researchers discover a link between bacterial infections and Alzheimer’s disease
UW Bioengineering's Valerie Daggett and other UW researchers discover a link between bacterial infections and Alzheimer's disease (AD)
Valerie Daggett receives the University Faculty Lecture Award
Valerie Daggett, UW professor of bioengineering, received the 2023 University Faculty Lecture Award. Valerie Daggett will deliver a campus-wide lecture in 2024.
Unveiling therapeutic potential: Exploring the link between Alzheimer’s and Type 2 diabetes
UW Bioengineering Professor Valerie Daggett discussed groundbreaking research on protein aggregation in Type 2 diabetes and Alzheimer's disease.
Addressing drug-resistant pathogens by targeting their protective biofilms
Each year, approximately 35 million adults receive inpatient care in US hospitals. More than [...]
UW News features Valerie Daggett’s groundbreaking Alzheimer’s diagnostic test
A team led by researchers at the University of Washington has developed a laboratory test that can measure levels of amyloid beta oligomers in blood samples.
Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer’s disease, researchers show
Researchers led by UW Department of Bioengineering Professor Valerie Daggett have developed synthetic peptides that can target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease. The team reports their achievement in a paper published the week of April 15 in the Proceedings of the National Academy of Sciences.
Valerie Daggett, Wendy Thomas, Rong Tian and Chun Yuan inducted as 2017 AIMBE Fellows
UW Bioengineering faculty Valerie Daggett, Wendy Thomas, Rong Tian and Chun Yuan were inducted to the AIMBE College of Fellows Class of 2017. 29 BioE core and adjunct faculty are AIMBE Fellows, and this year's class is the largest inducted in the department's history.
Patrick Stayton, Valerie Daggett to present 2016-17 Science in Medicine Lectures
Patrick Stayton, the Distinguished Career Professor of Bioengineering and director of the UW Molecular Engineering and Sciences Institute, and Valerie Daggett, professor of bioengineering, will present 2016-2017 UW Medicine Science in Medicine Lectures.
Suzie Pun and Valerie Daggett elected AIMBE Fellows
UW Bioengineering Professors Suzie Pun and Valerie Daggett have been elected to the AIMBE College of Fellows Class of 2015. Drs. Pun and Daggett join UW Bioengineering's 18 other AIMBE Fellows. AIMBE, or the American Institute for Medical and Biological Engineering,is a non-profit advocacy organization dedicated to improving lives through medical and biological engineering.
Nobel Laureate Michael Levitt to present December 2014 UW Walker Ames Lecture
UW Bioengineering Professor Dr. Valerie Daggett is hosting December 2014's UW Walker Ames lecturer, Dr. Michael Levitt, the Robert W. Vivian K. Cahill Professor of Cancer Research in the Department of Structural Biology at Stanford School of Medicine. Dr. Levitt is a 2013 Nobel Laureate in Chemistry and was also Dr. Daggett's postdoc advisor in the early 1990s.
Valerie Daggett’s research featured in Alaska Airlines magazine
UW Bioengineering Professor Dr. Valerie Daggett's research was featured in an article, "Innovative Medicine", published in the November 2014 issue of Alaska Airlines Magazine. The article discussed novel approaches to treating complex diseases currently being developed by Seattle-area researchers, and details Dr. Daggett's work designing peptides to neutralize harmful changes to proteins thought to have a role in amyloid diseases like Alzheimer's.
New protein structure could help treat Alzheimer’s, related diseases
UW Bioengineering Professor Dr. Valerie Daggett and research team members have designed a peptide structure that can stop harmful changes of proteins in the body that are linked to diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease (ALS).